Clinical colorectal cancer

Keyphrases

Publications

2024

Seijong Kim, Jung Kyong Shin, Yoonah Park, Jung Wook Huh, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee, Yong Beom Cho
Potential for Metastasis and Recurrence in Colorectal Carcinoma In Situ: A Retrospective Analysis of 1069 Patients. Clinical colorectal cancer (2024)
Oliver Piercey, Jeanne Tie, Frederic Hollande, Hui-Li Wong, John Mariadason, Jayesh Desai
BRAF V600E -Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities. Clinical colorectal cancer (2024)
Richard Kim, Mustapha Tehfe, Petr Kavan, Jorge Chaves, Jeremy S Kortmansky, Eric X Chen, Christopher H Lieu, Lucas Wong, Marwan Fakih, Kristen Spencer, Qing Zhao, Raluca Predoiu, Chenxiang Li, Pierre Leconte, David Adelberg, E Gabriela Chiorean
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D. Clinical colorectal cancer (2024)
Eric D Miller, Brett G Klamer, Jordan M Cloyd, Timothy M Pawlik, Terence M Williams, Kathryn E Hitchcock, Paul B Romesser, Harvey J Mamon, Kimmie Ng, Sepideh Gholami, George J Chang, Christopher J Anker
Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review. Clinical colorectal cancer (2024)
Soo Young Oh, Chan Wook Kim, Seonok Kim, Min Hyun Kim, Young Il Kim, Jong Lyul Lee, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Chang Sik Yu
Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis. Clinical colorectal cancer (2024)
Eric D Miller, Brett G Klamer, Jordan M Cloyd, Timothy M Pawlik, Terence M Williams, Kathryn E Hitchcock, Paul B Romesser, Harvey J Mamon, Kimmie Ng, Sepideh Gholami, George J Chang, Christopher J Anker
Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review. Clinical colorectal cancer (2024)
Charlène J van der Zijden, Hermien W H Schreurs, Sjoerd van den Hoek, Anne M van Geel, Jan Willem T Dekker, Daphne Roos
The Effect of (Chemo)Radiotherapy on Enlarged Lateral Lymph Nodes in Patients With Locally Advanced Rectal Cancer. Clinical colorectal cancer (2024)
Hideaki Bando, Toshihiro Misumi, Yasutoshi Sakamoto, Yuriko Takeda, Yoshiaki Nakamura, Kazuya Mizuguchi, Yoshihiro Aoyagi, Izumi Miki, Tomohiro Kuroda, Ryu Kasai, Takuya Suzuki, Takayuki Yoshino, Atsushi Ohtsu
Appropriate Relevancy and Reliability of Real-World Data for the Utilization of Regulatory Submission. Clinical colorectal cancer (2024)

volume 23, number 1, 2024

Tao Pan, Hui Yang, Wu-Yi Wang, Yuan-Yi Rui, Zi-Jian Deng, Yung-Chang Chen, Chao Liu, Hai Hu
Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal Cancer: A Preliminary Report of Case Series. Clinical colorectal cancer 23 (1) (2024)
Oliver Piercey, Hui-Li Wong, Clara Leung, Yat Hang To, Valerie Heong, Margaret Lee, Jeanne Tie, Malcolm Steel, Justin M Yeung, Jacob McCormick, Peter Gibbs, Rachel Wong
Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence. Clinical colorectal cancer 23 (1) (2024)
Oliver Piercey, Hui-Li Wong, Clara Leung, Yat Hang To, Valerie Heong, Margaret Lee, Jeanne Tie, Malcolm Steel, Justin M Yeung, Jacob McCormick, Peter Gibbs, Rachel Wong
Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence. Clinical colorectal cancer 23 (1) (2024)
Tao Pan, Hui Yang, Wu-Yi Wang, Yuan-Yi Rui, Zi-Jian Deng, Yung-Chang Chen, Chao Liu, Hai Hu
Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal Cancer: A Preliminary Report of Case Series. Clinical colorectal cancer 23 (1) (2024)
Tao Pan, Hui Yang, Wu-Yi Wang, Yuan-Yi Rui, Zi-Jian Deng, Yung-Chang Chen, Chao Liu, Hai Hu
Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal Cancer: A Preliminary Report of Case Series. Clinical colorectal cancer 23 (1) (2024)
Oliver Piercey, Hui-Li Wong, Clara Leung, Yat Hang To, Valerie Heong, Margaret Lee, Jeanne Tie, Malcolm Steel, Justin M Yeung, Jacob McCormick, Peter Gibbs, Rachel Wong
Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence. Clinical colorectal cancer 23 (1) (2024)

volume 23, number 2, 2024

Dorien Geusens, Daan Dierickx, Saskia Carton, Eric Van Cutsem, Jeroen Dekervel
Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review. Clinical colorectal cancer 23 (2) (2024)
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Akiyoshi Kanazawa, Koji Ando, Yosuke Horita, Masahiro Goto, Naohiro Okano, Toshikazu Moriwaki, Taroh Satoh, Akihito Tsuji, Kaname Yamashita, Chiharu Asano, Yukiko Abe, Shogo Nomura, Takayuki Yoshino
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study. Clinical colorectal cancer 23 (2) (2024)
Eric D Miller, Brett G Klamer, Jordan M Cloyd, Timothy M Pawlik, Terence M Williams, Kathryn E Hitchcock, Paul B Romesser, Harvey J Mamon, Kimmie Ng, Sepideh Gholami, George J Chang, Christopher J Anker
Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review. Clinical colorectal cancer 23 (2) (2024)
Richard Kim, Mustapha Tehfe, Petr Kavan, Jorge Chaves, Jeremy S Kortmansky, Eric X Chen, Christopher H Lieu, Lucas Wong, Marwan Fakih, Kristen Spencer, Qing Zhao, Raluca Predoiu, Chenxiang Li, Pierre Leconte, David Adelberg, E Gabriela Chiorean
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D. Clinical colorectal cancer 23 (2) (2024)
Richard Kim, Mustapha Tehfe, Petr Kavan, Jorge Chaves, Jeremy S Kortmansky, Eric X Chen, Christopher H Lieu, Lucas Wong, Marwan Fakih, Kristen Spencer, Qing Zhao, Raluca Predoiu, Chenxiang Li, Pierre Leconte, David Adelberg, E Gabriela Chiorean
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D. Clinical colorectal cancer 23 (2) (2024)
Hideaki Bando, Toshihiro Misumi, Yasutoshi Sakamoto, Yuriko Takeda, Yoshiaki Nakamura, Kazuya Mizuguchi, Yoshihiro Aoyagi, Izumi Miki, Tomohiro Kuroda, Ryu Kasai, Takuya Suzuki, Takayuki Yoshino, Atsushi Ohtsu
Appropriate Relevancy and Reliability of Real-World Data for the Utilization of Regulatory Submission. Clinical colorectal cancer 23 (2) (2024)
Dorien Geusens, Daan Dierickx, Saskia Carton, Eric Van Cutsem, Jeroen Dekervel
Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review. Clinical colorectal cancer 23 (2) (2024)
Eric D Miller, Brett G Klamer, Jordan M Cloyd, Timothy M Pawlik, Terence M Williams, Kathryn E Hitchcock, Paul B Romesser, Harvey J Mamon, Kimmie Ng, Sepideh Gholami, George J Chang, Christopher J Anker
Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review. Clinical colorectal cancer 23 (2) (2024)
Charlène J van der Zijden, Hermien W H Schreurs, Sjoerd van den Hoek, Anne M van Geel, Jan Willem T Dekker, Daphne Roos
The Effect of (Chemo)Radiotherapy on Enlarged Lateral Lymph Nodes in Patients With Locally Advanced Rectal Cancer. Clinical colorectal cancer 23 (2) (2024)
Hideaki Bando, Toshihiro Misumi, Yasutoshi Sakamoto, Yuriko Takeda, Yoshiaki Nakamura, Kazuya Mizuguchi, Yoshihiro Aoyagi, Izumi Miki, Tomohiro Kuroda, Ryu Kasai, Takuya Suzuki, Takayuki Yoshino, Atsushi Ohtsu
Appropriate Relevancy and Reliability of Real-World Data for the Utilization of Regulatory Submission. Clinical colorectal cancer 23 (2) (2024)
Soo Young Oh, Chan Wook Kim, Seonok Kim, Min Hyun Kim, Young Il Kim, Jong Lyul Lee, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Chang Sik Yu
Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis. Clinical colorectal cancer 23 (2) (2024)
Eric X Chen, Petr Kavan, Mustapha Tehfe, Jeremy S Kortmansky, Michael B Sawyer, E Gabriela Chiorean, Christopher H Lieu, Blase Polite, Lucas Wong, Marwan Fakih, Kristen Spencer, Jorge Chaves, Chenxiang Li, Pierre Leconte, David Adelberg, Richard Kim
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E. Clinical colorectal cancer 23 (2) (2024)
Daisuke Kotani, Atsuo Takashima, Takeshi Kato, Taroh Satoh, Toshiki Masuishi, Yoshito Komatsu, Manabu Shiozawa, Taito Esaki, Naoki Izawa, Shinji Takeuchi, Hideaki Bando, Satoru Iwasa, Hiroko Hasegawa, Toshifumi Yamaguchi, Hiroya Taniguchi, Yasunori Ushida, Toshiya Oizaki, Chiaki Inoue, Takayuki Yoshino
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF V600E -Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program. Clinical colorectal cancer 23 (2) (2024)
Daisuke Kotani, Atsuo Takashima, Takeshi Kato, Taroh Satoh, Toshiki Masuishi, Yoshito Komatsu, Manabu Shiozawa, Taito Esaki, Naoki Izawa, Shinji Takeuchi, Hideaki Bando, Satoru Iwasa, Hiroko Hasegawa, Toshifumi Yamaguchi, Hiroya Taniguchi, Yasunori Ushida, Toshiya Oizaki, Chiaki Inoue, Takayuki Yoshino
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF V600E -Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program. Clinical colorectal cancer 23 (2) (2024)
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Akiyoshi Kanazawa, Koji Ando, Yosuke Horita, Masahiro Goto, Naohiro Okano, Toshikazu Moriwaki, Taroh Satoh, Akihito Tsuji, Kaname Yamashita, Chiharu Asano, Yukiko Abe, Shogo Nomura, Takayuki Yoshino
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study. Clinical colorectal cancer 23 (2) (2024)
Eric X Chen, Petr Kavan, Mustapha Tehfe, Jeremy S Kortmansky, Michael B Sawyer, E Gabriela Chiorean, Christopher H Lieu, Blase Polite, Lucas Wong, Marwan Fakih, Kristen Spencer, Jorge Chaves, Chenxiang Li, Pierre Leconte, David Adelberg, Richard Kim
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E. Clinical colorectal cancer 23 (2) (2024)

volume 23, number 3, 2024

Sarah Unrau, Mansi Barthwal, Lavanya Gurram, Mirette Edward, Scott Hurton, Christina Kim, Maged Nashed
Clinical Outcomes in T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study. Clinical colorectal cancer 23 (3) (2024)
Seijong Kim, Jung Kyong Shin, Yoonah Park, Jung Wook Huh, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee, Yong Beom Cho
Potential for Metastasis and Recurrence in Colorectal Carcinoma In Situ: A Retrospective Analysis of 1069 Patients. Clinical colorectal cancer 23 (3) (2024)
Diogo Diniz Gomes Bugano, Vanessa Montes Santos, Arinilda Campos-Bragagnoli, Julia Carole Medeiros Melo, Luis Gustavo Capochin Romagnolo, Osmar Barbosa Neto, Icaro Thiago Carvalho, Juliana Karassawa-Helito, Cinthia D Ortega, Cassia Franco Tridente, Lucas Soares Gerbasi, Francisco Tustumi, Poliana Bergamaschine Giovani Blasi, Marleny Novaes Figueiredo de Araujo, Rafael Vaz Pandini, Victor Edmond Seid, Ana Sarah Portilho, Albert Buosso, Fabiana Rolla, Guilherme de Paula Pinto Schettino, Sergio Eduardo Alonso Araujo
Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer. Clinical colorectal cancer 23 (3) (2024)
Alberto Bessudo, Abdul Mustajeeb Haseeb, James A Reeves, Xiaofu Zhu, Lucas Wong, Vincent Giranda, Leah Suttner, Fang Liu, Manash Chatterjee, Sunil Sharma
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer. Clinical colorectal cancer 23 (3) (2024)
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, Ben X Wang, Jeffrey P Bruce, Farnoosh Abbas-Aghababazadeh, Maria Vila-Casadesús, Enrique Sanz-Garcia, S Y Cindy Yang, Hal K Berman, Ana Vivancos, Bernard Lam, Ilinca Lungu, Abdulazeez Salawu, Lee-Anne Stayner, Benjamin Haibe-Kains, Philippe L Bedard, Lisa Avery, Albiruni R A Razak, Trevor J Pugh, Anna Spreafico, Lillian L Siu, Aaron R Hansen
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer. Clinical colorectal cancer 23 (3) (2024)
Zdravko P Vassilev, Xiaozhou Fan, Julie Xu, Helene Ostojic, Afsaneh Barzi
Use of FOLFOXIRI Plus Bevacizumab and Subsequent Therapies in Metastatic Colorectal Cancer: An Age-Stratified Analysis. Clinical colorectal cancer 23 (3) (2024)
Annie Xiao, Marwan Fakih
KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer. Clinical colorectal cancer 23 (3) (2024)
L Hulst, S Cappuyns, F Peeters, F Vulsteke, F Van Herpe, E Van Cutsem, J Dekervel
Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study. Clinical colorectal cancer 23 (3) (2024)
Oliver Piercey, Jeanne Tie, Frederic Hollande, Hui-Li Wong, John Mariadason, Jayesh Desai
BRAF V600E -Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities. Clinical colorectal cancer 23 (3) (2024)
Diogo Diniz Gomes Bugano, Vanessa Montes Santos, Arinilda Campos-Bragagnoli, Julia Carole Medeiros Melo, Luis Gustavo Capochin Romagnolo, Osmar Barbosa Neto, Icaro Thiago Carvalho, Juliana Karassawa-Helito, Cinthia D Ortega, Cassia Franco Tridente, Lucas Soares Gerbasi, Francisco Tustumi, Poliana Bergamaschine Giovani Blasi, Marleny Novaes Figueiredo de Araujo, Rafael Vaz Pandini, Victor Edmond Seid, Ana Sarah Portilho, Albert Buosso, Fabiana Rolla, Guilherme de Paula Pinto Schettino, Sergio Eduardo Alonso Araujo
Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer. Clinical colorectal cancer 23 (3) (2024)
Zdravko P Vassilev, Xiaozhou Fan, Julie Xu, Helene Ostojic, Afsaneh Barzi
Use of FOLFOXIRI Plus Bevacizumab and Subsequent Therapies in Metastatic Colorectal Cancer: An Age-Stratified Analysis. Clinical colorectal cancer 23 (3) (2024)
Seijong Kim, Jung Kyong Shin, Yoonah Park, Jung Wook Huh, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee, Yong Beom Cho
Potential for Metastasis and Recurrence in Colorectal Carcinoma In Situ: A Retrospective Analysis of 1069 Patients. Clinical colorectal cancer 23 (3) (2024)
Annie Xiao, Marwan Fakih
KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer. Clinical colorectal cancer 23 (3) (2024)
Francesc Salvà, Nadia Saoudi, Marta Rodríguez, Iosune Baraibar, Javier Ros, Ariadna García, Josep Tabernero, Elena Elez
Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease. Clinical colorectal cancer 23 (3) (2024)
L Hulst, S Cappuyns, F Peeters, F Vulsteke, F Van Herpe, E Van Cutsem, J Dekervel
Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study. Clinical colorectal cancer 23 (3) (2024)
Alberto Bessudo, Abdul Mustajeeb Haseeb, James A Reeves, Xiaofu Zhu, Lucas Wong, Vincent Giranda, Leah Suttner, Fang Liu, Manash Chatterjee, Sunil Sharma
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer. Clinical colorectal cancer 23 (3) (2024)
Francesc Salvà, Nadia Saoudi, Marta Rodríguez, Iosune Baraibar, Javier Ros, Ariadna García, Josep Tabernero, Elena Elez
Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease. Clinical colorectal cancer 23 (3) (2024)
Oliver Piercey, Jeanne Tie, Frederic Hollande, Hui-Li Wong, John Mariadason, Jayesh Desai
BRAF V600E -Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities. Clinical colorectal cancer 23 (3) (2024)
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, Ben X Wang, Jeffrey P Bruce, Farnoosh Abbas-Aghababazadeh, Maria Vila-Casadesús, Enrique Sanz-Garcia, S Y Cindy Yang, Hal K Berman, Ana Vivancos, Bernard Lam, Ilinca Lungu, Abdulazeez Salawu, Lee-Anne Stayner, Benjamin Haibe-Kains, Philippe L Bedard, Lisa Avery, Albiruni R A Razak, Trevor J Pugh, Anna Spreafico, Lillian L Siu, Aaron R Hansen
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer. Clinical colorectal cancer 23 (3) (2024)
Sarah Unrau, Mansi Barthwal, Lavanya Gurram, Mirette Edward, Scott Hurton, Christina Kim, Maged Nashed
Clinical Outcomes in T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study. Clinical colorectal cancer 23 (3) (2024)